Lombard Odier & Cie (Bahamas)’s AstraZeneca AZN Stock Holding History

Lombard Odier & Cie (Bahamas)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$21K	Hold	330	–	–	0.01%	73
2015 Q2	$21K	Hold	330	–	–	0.01%	80
2015 Q1	$23K	Hold	330	–	–	0.01%	77
2014 Q4	$23K	Hold	330	–	–	0.01%	70
2014 Q3	$24K	Hold	330	–	–	0.01%	77
2014 Q2	$25K	Hold	330	–	–	0.01%	90
2014 Q1	$21K	Hold	330	–	–	0.01%	98
2013 Q4	$20K	Buy	+330	New	+$17.9K	0.01%	108

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Lombard Odier & Cie (Bahamas)'s AZN Position: Q3 2015 in Review

Lombard Odier & Cie (Bahamas) held its AstraZeneca (AZN) position steady in Q3 2015 at 330 shares worth $21K. The position accounts for 0.01% of the portfolio, ranked #73.

Lombard Odier & Cie (Bahamas) first reported a position in AZN in Q4 2013 and has held it in 8 quarters since. The position peaked at $25K in Q2 2014. 371 funds tracked by Wall St. Rank hold AZN as of Q3 2015.

Lombard Odier & Cie (Bahamas) held 330 shares of AstraZeneca worth $21K as of Q3 2015.
Lombard Odier & Cie (Bahamas) left its AstraZeneca share count unchanged in Q3 2015.
AstraZeneca made up 0.01% of Lombard Odier & Cie (Bahamas)'s portfolio in Q3 2015, its #73 holding.
Lombard Odier & Cie (Bahamas) first reported a position in AstraZeneca in Q4 2013 and has held it in 8 quarters since.
Lombard Odier & Cie (Bahamas)'s AstraZeneca position peaked at $25K in Q2 2014.
371 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2015.

Based on Lombard Odier & Cie (Bahamas)'s 13F filing for Q3 2015, filed 13 Nov 2015.